Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website https://www.gastrores.org

Original Article

Volume 15, Number 3, June 2022, pages 120-126

Investigating Defects of Esophageal Motility in Lung Transplant Recipients

Figure

Figure 1.
Figure 1. Algorithm for screening, monitoring, and treatment of lung transplant recipients for reflux and gastroparesis. GERD: gastroesophageal reflux disease; EGD: esophagogastroduodenoscopy; HRM: high-resolution manometry; BOS: bronchitis obliterans syndrome.

Tables

Table 1. Total Number and Percent of Abnormal Post-Transplant Gastrointestinal Studies
 
Post-transplant patients with abnormal results
Impedance test62% (37/60)
High-resolution manometry83% (50/60)
pH test37% (22/60)

 

Table 2. Mortality and Rejection Rates Associated With Abnormal Post-Transplant Gastrointestinal Studies
 
BOS incidenceRejection rate
BOS: bronchitis obliterans syndrome.
Abnormal impedance test71% (5/7)67% (25/37)
Abnormal high-resolution manometry28% (2/7)66% (33/50)
Abnormal pH test14% (1/7)63% (14/22)

 

Table 3. Odds Ratio (OR) for Abnormal Motility Studies and Acute Cellular Rejection With Confidence Interval (CI)
 
Abnormal variableNo rejection (n = 19)Rejection (n = 41)OR (95% CI)
HRM: high-resolution manometry.
Impedance12 (63%)25 (61%)1.09 (0.31, 4.03), P = 1.00
HRM17 (89%)33 (80%)2.03 (0.35, 21.80), P = 1.00
pH study8 (42%)14 (34%)1.39 (0.39, 4.89), P = 1.00